These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30881922)

  • 21. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
    Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-Linked Glycosylation Is Not Essential for Sodium Taurocholate Cotransporting Polypeptide To Mediate Hepatitis B Virus Infection
    Lee J; Zong L; Krotow A; Qin Y; Jia L; Zhang J; Tong S; Li J
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29793953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma.
    Yin J; Xie J; Zhang H; Shen Q; Han L; Lu W; Han Y; Li C; Ni W; Wang H; Cao G
    J Gastroenterol; 2010 Oct; 45(10):1063-71. PubMed ID: 20419326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NTCP polymorphisms were associated with fibrosis development in patients with chronic HBV infection.
    Su Z; Cai B; Wu X; Li L; Wei B; Meng L; Wang L; Wang L
    J Infect Dev Ctries; 2022 Jan; 16(1):179-186. PubMed ID: 35192536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in sodium taurocholate cotransporting polypeptide are not associated with hepatitis B virus clearance in Chinese Tibetans and Uygurs.
    Su Z; Li Y; Liao Y; Cai B; Chen J; Zhang J; Li L; Ying B; Tao C; Zhao M; Ba Z; Zhang Z; Wang L
    Infect Genet Evol; 2016 Jul; 41():128-134. PubMed ID: 27051045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PreS deletion profiles of hepatitis B virus (HBV) are associated with clinical presentations of chronic HBV infection.
    Li X; Qin Y; Liu Y; Li F; Liao H; Lu S; Qiao Y; Xu D; Li J
    J Clin Virol; 2016 Sep; 82():27-32. PubMed ID: 27415434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host genetic background affects the course of infection and treatment response in patients with chronic hepatitis B.
    Rybicka M; Woziwodzka A; Romanowski T; Sznarkowska A; Stalke P; Dręczewski M; Bielawski KP
    J Clin Virol; 2019 Nov; 120():1-5. PubMed ID: 31505315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes.
    König A; Döring B; Mohr C; Geipel A; Geyer J; Glebe D
    J Hepatol; 2014 Oct; 61(4):867-75. PubMed ID: 24845614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver.
    Nakabori T; Hikita H; Murai K; Nozaki Y; Kai Y; Makino Y; Saito Y; Tanaka S; Wada H; Eguchi H; Takahashi T; Suemizu H; Sakamori R; Hiramatsu N; Tatsumi T; Takehara T
    Sci Rep; 2016 Jun; 6():27782. PubMed ID: 27278060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infection.
    Ueda Y; Gu W; Dansako H; Nishitsuji H; Satoh S; Shimotohno K; Kato N
    Biochem Biophys Res Commun; 2019 Jul; 515(1):156-162. PubMed ID: 31133379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of the gene polymorphisms in sodium taurocholate cotransporting polypeptide with the outcomes of hepatitis B infection in Chinese Han population.
    Su Z; Li Y; Liao Y; Cai B; Chen J; Zhang J; Li L; Ying B; Tao C; Wang L
    Infect Genet Evol; 2014 Oct; 27():77-82. PubMed ID: 25010264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes.
    Song XM; Li QL; Guo F; Peng H; Guo JJ
    Ann Hepatol; 2018 Oct; 17(6):940-947. PubMed ID: 30600290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Single Adaptive Mutation in Sodium Taurocholate Cotransporting Polypeptide Induced by Hepadnaviruses Determines Virus Species Specificity.
    Takeuchi JS; Fukano K; Iwamoto M; Tsukuda S; Suzuki R; Aizaki H; Muramatsu M; Wakita T; Sureau C; Watashi K
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus infection in Taiwan: The role of NTCP rs2296651 variant in relation to sex.
    Nfor ON; Wu MF; Debnath T; Lee CT; Lee W; Liu WH; Tantoh DM; Hsu SY; Liaw YP
    J Viral Hepat; 2018 Oct; 25(10):1116-1120. PubMed ID: 29660219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three types of preS1 start codon deletion variants in the natural course of chronic hepatitis B infection.
    Choe WH; Kim H; Lee SY; Choi YM; Kwon SY; Moon HW; Hur M; Kim BJ
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1370-1378. PubMed ID: 29232004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The NTCP p.Ser267Phe Variant Is Associated With a Faster Anti-HBV Effect on First-Line Nucleos(t)ide Analog Treatment.
    Wu L; Xu W; Li X; Liu Y; Wang L; Zhu S; Yang F; Xie C; Peng L
    Front Pharmacol; 2021; 12():616858. PubMed ID: 33716744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variants of NTCP gene and hepatitis B vaccine failure in Taiwanese children of hepatitis B e antigen positive mothers.
    Chen YH; Tsuei DJ; Lai MW; Wen WH; Chiang CL; Wu JF; Chen HL; Hsu HY; Ni YH; Chang MH
    Hepatol Int; 2022 Aug; 16(4):789-798. PubMed ID: 35635688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
    Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
    Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NTCP gene polymorphisms and hepatitis B virus infection status in a Ghanaian population.
    Nyarko E; Obirikorang C; Owiredu WKBA; Adu EA; Acheampong E; Aidoo F; Ofori E; Addy BS; Asare-Anane H
    Virol J; 2020 Jul; 17(1):91. PubMed ID: 32620148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are Humanized Mouse Models Useful for Basic Research of Hepatocarcinogenesis through Chronic Hepatitis B Virus Infection?
    Tsuge M
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.